Please login to the form below
Trump
This page shows the latest Trump news and features for those working in and with pharma, biotech and healthcare.
Not another thought leadership article… sorting the wheat from the chaff
There is simply too much content to consume. In the study, nearly 40% of respondents agreed, so surely we should take that as a mandate that quantity no longer trumps quality.
Latest news
-
UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains
Remdesivir has been touted as a potential treatment for COVID-19 since the early days of the pandemic, with the drug recently being administered to US president Donald Trump after he
-
Janet Woodcock named acting commissioner of the FDA
Under his leadership, the FDA was criticised by ex-President Trump over the agency’s timeline for approving COVID-19 vaccines. ... President Biden also began the process of reversing Trump's controversial decision to withdraw the US from the World
-
Pfizer, Sanofi and others set to increase US drug prices in 2021
Soaring drug prices had been a key issue for the Trump administration, with the outgoing US president issuing several executive orders in late 2020 aimed at lowering prices.
-
WHO trial casts doubt on remdesivir's efficacy
Remdesivir has been touted as a potential treatment for COVID-19 since the early days of the pandemic, with the drug recently being administered to US president Donald Trump after he
-
Regeneron scores first FDA approval for Ebola antibody treatment
The antibody cocktail, REGN-COV2, was recently given to US president Donald Trump after he tested positive for coronavirus earlier this month.
More from news
Approximately 45 fully matching, plus 103 partially matching documents found.
Latest Intelligence
-
Is there such a thing as the new normal? Or is it simply the ‘here and now’?
The two-year pre-launch window is a critical time, influencing how successful a product will be, but there is one de-railer that trumps them all – complacency.
-
NICE – but not enough
Driving implementation isn’t easy, irrespective of NICE directives; the NHS moves slowly, and local factors will invariably trump national mandates.
-
Eliminating pharmaceutical rebates, is this déjà vu?
In July 2020, the Trump administration announced its intention, for the second time, to prohibit rebates for Medicare Part D drugs within PBMs as one of several new Executive Orders aimed
-
COVID-19: the race to find a vaccine
Other antivirals including hydroxychloroquine – a drug championed by President Donald Trump – and favipiravir are also in clinical development, raising hopes that researchers will find a drug with some level of efficacy
-
As COVID-19 takes over the world, biopharma fights back
A standard malaria treatment: chloroquine and hydroxychloroquine. A decades-old antimalaria drug, chloroquine, entered the global spotlight in March after US President Donald Trump touted it as a potentially effective coronavirus
More from intelligence
Approximately 4 fully matching, plus 23 partially matching documents found.
Latest from PMHub
-
The Seven Year Switch
The UK was in the EU, Donald Trump was only really known for being an orange TV personality, and TikTok was just the noise a clock made. ... People’s relationships have become strained and defined by their views on Trump, Brexit, vaccines and global
-
A masterclass in corporate communications
Today’s fast-moving 24-hour news cycle prizes headlines and soundbites over comprehensiveness, where controversy trumps nuance.
-
Should there be a punishment?
It results in commoditisation as market competitors out-trump one another with new features and competitive pricing.
-
Fake News is Bad for your Health
in Italy, while Donald Trump has repeatedly tweeted that MMR vaccine causes autism.
-
'Fake news': battling misinformation in healthcare
In an era where ‘fake news’ has become a trending phrase used by political leaders – from Trump and Putin to UK members of parliament – it feels as if we’re all
More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- FDA external report recommends actions to address US opioid crisis
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Congress is in session – how companies are boosting their impact and engagement
- AstraZeneca announces major expansion of Canadian research footprint
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Genesis Research
Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
